Ignite Creation Date:
2024-05-06 @ 1:13 PM
Last Modification Date:
2024-10-26 @ 1:11 PM
Study NCT ID:
NCT03969121
Status:
COMPLETED
Last Update Posted:
2023-03-10
First Post:
2019-05-13
Brief Title:
Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable Hormone Sensitive and HER2-Negative Primary Breast Cancer
Sponsor:
Kyoto Breast Cancer Research Network
Organization:
Kyoto Breast Cancer Research Network
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-16
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-23
Completion Date Type:
ACTUAL
First Submit Date:
2019-05-13
First Submit QC Date:
May 29 2019
Study First Post Date:
2019-05-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-09
Last Update Post Date:
2023-03-10
Last Update Post Date Type:
ACTUAL